Literature DB >> 30236391

Prospective Multicenter Experience With Cooled Radiofrequency Ablation Using High Impedance Irrigant to Target Deep Myocardial Substrate Refractory to Standard Ablation.

Duy T Nguyen1, Wendy S Tzou1, Amneet Sandhu1, Carola Gianni2, Elad Anter3, Roderick Tung4, Miguel Valderrábano5, Patrick Hranitzky6, Kyoko Soeijma7, Luis Saenz8, Fermin C Garcia9, Usha B Tedrow10, John M Miller11, Edward P Gerstenfeld12, J David Burkhardt2, Andrea Natale2, William H Sauer13.   

Abstract

OBJECTIVES: This study sought to evaluate the efficacy and safety of using half-normal saline (HNS) as the cooling radiofrequency ablation (RFA) irrigant among patients who had failed prior, standard RFA.
BACKGROUND: Effective control of ventricular arrhythmias that arise from mid-myocardium may be refractory to standard RFA. Recent data suggest that delivering fluid with decreased ionic concentration during open-irrigated RFA can produce deeper RFA lesions.
METHODS: A 12-center prospective analysis was performed of all ablations using HNS for the treatment of ventricular arrhythmias (premature ventricular complex [PVC]/ventricular tachycardia [VT]) refractory to standard ablation with normal saline irrigant.
RESULTS: HNS RFA was used clinically to target 94 PVC/VTs refractory to standard ablation. Acute success was achieved in 78 of 94 (83%), with longer-term success occurring in 78 subjects after a mean follow-up of 6.1 ± 6.7 months (range, 3.0 to 25.2 months). Steam pops were observed among 12 (12.6%) patients. There were no significant changes in electrolytes measured before and after the use of HNS, and there were no complications related to HNS use.
CONCLUSIONS: The use of HNS instead of normal saline irrigant during high-power delivery targeting deep myocardial substrate is safe and effective. PVC/VT sources previously unaffected by standard ablation may be successfully ablated with improved efficiency of radiofrequency delivery using HNS.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ablation; radiofrequency; ventricular arrhythmias

Mesh:

Year:  2018        PMID: 30236391     DOI: 10.1016/j.jacep.2018.06.021

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  21 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate.

Authors:  Ayelet Shapira-Daniels; Michael Barkagan; Markus Rottmann; Jakub Sroubek; Derin Tugal; Michael A Carlozzi; James W McConville; Alfred E Buxton; Elad Anter
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-06

3.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 4.  Radiofrequency Ablation Strategies for Intramural Ventricular Arrhythmias.

Authors:  Naga Venkata K Pothineni; Fermin C Garcia; Pasquale Santangeli
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

Review 5.  Coronary Venous Mapping and Catheter Ablation for Ventricular Arrhythmias.

Authors:  Jackson J Liang; Frank Bogun
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

Review 6.  Innovations in ventricular tachycardia ablation.

Authors:  Qussay Marashly; Salim N Najjar; Joshua Hahn; Graham J Rector; Muzamil Khawaja; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-07-25       Impact factor: 1.759

Review 7.  Contemporary approach to catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.

Authors:  Sharma Kattel; Alan D Enriquez
Journal:  J Interv Card Electrophysiol       Date:  2022-09-03       Impact factor: 1.759

8.  Moving the needle: Tissue characterization and lesion formation during infusion-needle ablation.

Authors:  Duy T Nguyen; Sanjiv M Narayan
Journal:  Heart Rhythm       Date:  2019-10-12       Impact factor: 6.779

9.  Three-dimensional transmural mapping to guide ventricular arrhythmia ablation.

Authors:  Sanjiv M Narayan; Nitish Badhwar
Journal:  Heart Rhythm       Date:  2021-05-06       Impact factor: 6.779

10.  High-intensity ultrasound catheter ablation achieves deep mid-myocardial lesions in vivo.

Authors:  Babak Nazer; David Giraud; Yan Zhao; James Hodovan; Miriam R Elman; Ahmad Masri; Edward P Gerstenfeld; Jonathan R Lindner
Journal:  Heart Rhythm       Date:  2020-12-29       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.